An autoregulatory loop directs the tissue-specific expression of p63 through a long-range evolutionarily conserved enhancer

Molecular and Cellular Biology

Volumn 26, Issue 8, 2006, Pages 3308-3318

  Antonini, Dario ^a   Rossi, Barbara ^a   Han, Rong ^b   Minichiello, Annunziata ^a   Di Palma, Tina ^c   Corrado, Marcella ^a,d   Banfi, Sandro ^a   Zannini, Mariastella ^c   Brissette, Janice L ^b   Missero, Caterina ^a  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN P63; TRANSCRIPTION FACTOR AP 2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ECTODERM; EMBRYO DEVELOPMENT; ENHANCER REGION; EPIDERMIS; EXON; GENE; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; MAMMARY GLAND; MOUSE; MOUTH MUCOSA; NONHUMAN; P63 GENE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BETA-GALACTOSIDASE; BINDING SITES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CONSERVED SEQUENCE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENHANCER ELEMENTS (GENETICS); EVOLUTION, MOLECULAR; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, REPORTER; HELA CELLS; HUMANS; KERATINOCYTES; LUCIFERASES; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; NIH 3T3 CELLS; PROTEIN BINDING; PROTEIN ISOFORMS; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION FACTOR AP-2; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 33645829469     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.26.8.3308-3318.2006     Document Type: Article

References (42)

1. Bakkers, J., M. Hild, C. Kramer, M. Furutani-Seild, and M. Hammerschmidt. 2002. Zebrafish deltaNp63 is a direct target of Bmp signaling and encodes a transcriptional repressor blocking neural specification in the ventral ectoderm. Dev. Cell 2:617-627.
2. Bamberger, C., and H. Schmale. 2001. Identification and tissue distribution of novel KET/p63 splice variants. FEBS Lett. 501:121-126.
3. Barbieri, C. E., C. A. Perez, K. N. Johnson, K. A. Ely, D. Billheimer, and J. A. Pietenpol. 2005. IGFBP-3 is a direct target of transcriptional regulation by deltaNp63alpha in squamous epithelium. Cancer Res. 65:2314-2320.
4. Brudno, M., C. B. Do, G. M. Cooper, M. F. Kim, E. Davydov, E. D. Green, A. Sidow, and S. Batzoglou. 2003. LAGAN and Multi-LAGAN: efficient tools for large-scale multiple alignment of genomic DNA. Genome Res. 13:721-731.
5. Brummelkamp, T. R., R. Beruards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
6. Dermitzakis, E. T., A. Reymond, and S. E. Antonarakis. 2005. Conserved non-genie sequences-an unexpected feature of mammalian genomes. Nat. Rev. Genet. 6:151-157.
7. Dotto, G. P., R. A. Weinberg, and A. Ariza. 1988. Malignant transformation of mouse primary keratinocytes by Harvey sarcoma virus and its modulation by surrounding normal cells. Proc. Natl. Acad. Sci. USA 85:6389-6393.
8. Ellisen, L. W., K. D. Ramsayer, C. M. Johannessen, A. Yang, H. Beppu, K. Minda, J. D. Oliner, F. McKeon, and D. A. Haber. 2002. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol. Cell 10:995-1005.
9. Frank, S. R., M. Schroeder, P. Fernandez, S. Taubert, and B. Amati. 2001. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 15:2069-2082.
10. Ghioni, P., F. Bolognese, P. H. Duijf, H. Van Bokhoven, R. Mantovani, and L. Guerrini. 2002. Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. Mol. Cell. Biol. 22:8659-8668.
11. Harmes, D. C., E. Bresnick, E. A. Lubin, J. K. Watson, K. E. Heim, J. C. Curtin, A. M. Suskind, J. Lamb, and J. DiRenzo. 2003. Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes. Oncogene 22:7607-7616.
12. Hennings, H., D. Michael, C. Cheng, P. Steinert, K. Holbrook, and S. H. Yuspa. 1980. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-254.
13. Ihrie, R. A., M. R. Marques, B. T. Nguyen, J. S. Horner, C. Papazoglu, R. T. Bronson, A. A. Mills, and L. D. Attardi. 2005. Perp is a p63-regulated gene essential for epithelial integrity. Cell 120:843-856.
14. Jang, S. I., and P. M. Steinert. 2002. Loricrin expression in cultured human keratinocytes is controlled by a complex interplay between transcription factors of the Sp1, CREB, AP1, and AP2 families. J. Biol. Chem. 277:42268-42279.
15. Kaufman, C. K., S. Sinha, D. Bolotin, J. Fan, and E. Fuchs. 2002. Dissection of a complex enhancer element: maintenance of keratinocyte specificity but loss of differentiation specificity. Mol. Cell. Biol. 22:4293-4308.
16. Kel, A. E., E. Gossling, I. Reuter, E. Cheremushkin, O. V. Kel-Margoulis, and E. Wingender. 2003. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res. 31:3576-3579.
17. King, K. E., R. M. Ponnamperuma, T. Yamashita, T. Tokino, L. A. Lee, M. F. Young, and W. C. Weinberg. 2003. DeltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. Oncogene 22:3635-3644.
18. Kleinjan, D. A., and V. van Heyningen. 2005. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am. J. Hum. Genet. 76:8-32.
19. Koster, M. I., S. Kim, A. A. Mills, F. J. DeMayo, and D. R. Roop. 2004. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 18:126-131.
20. Leask, A., C. Byrne, and E. Fuchs. 1991. Transcription factor AP2 and its role in epidermal-specific gene expression. Proc. Natl. Acad. Sci. USA 88:7948-7952.
21. Lee, D., D. M. Prowse, and J. L. Brissette. 1999. Association between mouse nude gene expression and the initiation of epithelial terminal differentiation. Dev. Biol. 208:362-374.
22. Luo, T, M. Matsuo-Takasaki, M. L. Thomas, D. L. Weeks, and T. D. Sargent. 2002. Transcription factor AP-2 is an essential and direct regulator of epidermal development in Xenopus. Dev. Biol. 245:136-144.
23. Maytin, E. V., J. C. Lin, R. Krishnamurthy, N. Batchvarova, D. Ron, P. J. Mitchell, and J. F. Habener. 1999. Keratin 10 gene expression during differentiation of mouse epidermis requires transcription factors C/EBP and AP-2. Dev. Biol. 216:164-181.
24. McGrath, J. A., P. H. Duijf, V. Doetsch, A. D. Irvine, R. de Waal, K. R. Vanmolkot, V. Wessagowit, A. Kelly, D. J. Atherton, W. A. Griffiths, S. J. Orlow, A. van Haeringen, M. G. Ausems, A. Yang, F. McKeon, M. A. Bamshad, H. G. Brunner, B. C. Hamel, and H. van Bokhoven. 2001. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum. Mol. Genet. 10:221-229.
25. McPherson, L. A., and R. J. Weigel. 1999. AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs. Nucleic Acids Res. 27:4040-4049.
26. Mills, A. A., B. Zheng, X. J. Wang, H. Vogel, D. R. Roop, and A. Bradley. 1999. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713.
27. Mitchell, P. J., P. M. Timmons, J. M. Hebert, P. W. Rigby, and R. Tjian. 1991. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 5:105-119.
28. Ohno, M., M. Zannini, O. Levy, N. Carrasco, and R. di Lauro. 1999. The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol. Cell. Biol. 19:2051-2060.
29. Osada, M., M. Ohba, C. Kawahara, C. Ishioka, R. Kanamaru, I. Katoh, Y. Ikawa, Y. Nimura, A. Nakagawara, M. Obinata, and S. Ikawa. 1998. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med. 4:839-843.
30. Parsa, R., A. Yang, F. McKeon, and H. Green. 1999. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J. Investig. Dermatol. 113:1099-1105.
31. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878-4884.
32. Serber, Z., H. C. Lai, A. Yang, H. D. Ou, M. S. Sigal, A. E. Kelly, B. D. Darimont, P. H. Duijf, H. Van Bokhoven, F. McKeon, and V. Dotsch. 2002. A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Mol. Cell. Biol. 22:8601-8611.
33. Siepel, A., and D. Haussler. 2004. Phylogenetic estimation of context-dependent substitution rates by maximum likelihood. Mol. Biol. Evol. 21:468-488.
34. Sinha, S., L. Degenstein, C. Copenhaver, and E. Fuchs. 2000. Defining the regulatory factors required for epidermal gene expression. Mol. Cell. Biol. 20:2543-2555.
35. van Bokhoven, H., B. C. Hamel, M. Bamshad, E. Sangiorgi, F. Gurrieri. P. H. Duijf, K. R. Vanmolkot, E. van Beusekom, S. E. van Beersum, J. Celli, G. F. Merkx, R. Tenconi, J. P. Fryns, A. Verloes, R. A. Newbury-Ecob, A. Raas-Rotschild, F. Majewski, F. A. Beemer, A. Janecke, D. Chitayat, G. Crisponi, H. Kayserili, J. R. Yates, G. Neri, and H. G. Brunner. 2001. p63 gene mutations in EEC syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am. J. Hum. Genet. 69:481-492.
36. van Bokhoven, H., and F. McKeon. 2002. Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans. Trends Mol. Med. 8:133-139.
37. Waltermann, A., N. N. Kartasheva, and M. Dobbelstein. 2003. Differential regulation of p63 and p73 expression. Oncogene 22:5686-5693.
38. Westfall, M. D., D. J. Mays, J. C. Sniezek, and J. A. Pietenpol. 2003. The ΔNp63α phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol.Cell. Biol. 23:2264-2276.
39. Wu, G., S. Nomoto, M. O. Hoque, T. Dracheva, M. Osada, C. C. Lee, S. M. Dong, Z. Guo, N. Benoit, Y. Cohen, P. Rechthand, J. Califano, C. S. Moon, E. Ratovitski, J. Jen, D. Sidransky, and B. Trink. 2003. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res. 63:2351-2357.
40. Yang, A., M. Kaghad, Y. Wang, E. Gillett, M. D. Fleming, V. Dotsch, N. C. Andrews, D. Caput, and F. McKeon. 1998. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2:305-316.
41. Yang, A., R. Schweitzer, D. Sun, M. Kaghad, N. Walker, R. T. Bronson, C. Tabin, A. Sharpe, D. Caput, C. Crum, and F. McKeon. 1999. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714-718.
42. Yee, S. P., and P. W. Rigby. 1993. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev. 7:1277-1289.